Deepexi Technology Co., Ltd. （the “Deepexi”） is an enterprise large model AI application solution provider. With over 40 registered patents, Deepexi has participated in drafting several national standards in AI and industrial fields. Deepexi specializes in delivering cutting-edge artificial intelligence solutions for enterprises, empowering enterprises to integrate their professional knowledge and data, decisions and operations efficiently at scale.
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on share reform, and valuation services related to share-based compensation and preferred shares.
Congratulations again Deepexi Technology Co., Ltd. （1384.HK） on its successful listing. The issue price of the shares is  HKD26.66 per share, and the amount of funds raised is HKD710.01 million.
<img src="../../../../../uploads/1_908bce0acc.JPG" alt="" width="960" height="720" />

banner1

Congratulations to Deepexi Technology Co., Ltd. （1384.HK） on its successful Listing on the Mainboard of HKSE on 28 Oct 2025

Our Managing Partner, Mr. Vincent Pang, and Director, Ms. Sabrina Lam, had the honor of being invited as speakers by the Hong Kong Institute of Certified Public Accountants (HKICPA) to participate in 2nd Cohort of the GBA CPA Talent Class respectively.
Mr. Pang delivered an insightful presentation focusing on the requirements and issues of valuation in relation to M&amp;A transactions, accompanied by tasks upon completion of the transaction such as purchase price allocation and subsequent impairment assessment for the goodwill and intangible assets recognized in the transaction.
Ms. Lam’s presentation focused on the HKEX climate-related disclosure enhancement, including ESG reporting. Ms. Lam also shared valid examples to ensure her insights with fellow professionals were inspirational and enriching, such as navigating the key challenges for listed companies.
Drawing upon our deep expertise in business valuation and extensive industry experience, AVISTA Group is grateful for the opportunity to contribute to the advancement of the accounting profession through collaborations with the HKICPA. We eagerly anticipate future partnerships and opportunities to further enhance industry knowledge and practices.
 
<img src="../../../../../uploads/Image_6_08bdd86cde.jpg" alt="" width="800" height="600" />
<img src="../../../../../uploads/1_c0e451603f.jpg" alt="" width="800" height="600" />

As a speaker of the HKICPA’s 2nd Cohort of the GBA CPA Talent Class - Driving Excellence in Valuation and Sustainability

Congratulations to JST Group Corporation Limited (6687.HK) on its successful Listing on the Mainboard of HKSE on 21 Oct 2025
JST Group Corporation Limited (the “JST”) is a leading e-commerce SaaS ERP provider in China. JST’s offerings provide customers of different kinds and sizes a unified and intuitive way to monitor, operate and manage their businesses, and make data-driven intelligent decisions that help them excel in the fast-evolving e-commerce industry.
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on PPA, goodwill impairment test, long-term asset impairment test, share-based compensation, financial instruments and financial assets.
Congratulations again JST Group Corporation Limited (6687.HK) on its successful listing. The issue price of the shares is  HKD 30.6 per share, and the amount of funds raised is HKD 2,085.89 million.
<img src="../../../../../uploads/Slide1_0a51fbaa7c.JPG" alt="" width="960" height="720" />

Congratulations to JST Group Corporation Limited (6687.HK) on its Successful Listing

Congratulations to Fujian Haixi Pharmaceutical Co., Ltd. (2637.HK) on its successful Listing on the Mainboard of HKSE on 20 Oct 2025
Fujian Haixi Pharmaceutical Co., Ltd. (“Haixi Pharmaceutical”) is a commercial-stage pharmaceutical company that integrates R&amp;D, production and sales capacities, with a pipeline of innovative drug candidates. Haixi Pharmaceutical has a diversified product portfolio and pipeline in the largest and fastest growing therapeutic areas in China. Haixi Pharmaceutical’s commercialized product portfolio primarily consisted of generic drugs for digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases and inflammatory diseases.
With regard to this listing application, AVISTA Group is honored to be engaged in providing ESG advisory services, valuation services in relation to the financial asset and investment property.
Congratulations again Fujian Haixi Pharmaceutical Co., Ltd. (2637.HK) on its successful listing. The issue price of the shares is HKD86.4 per share, and the amount of funds raised is 993.6 million HKD.
<img src="../../../../../uploads/Slide1_79059e180b.JPG" alt="" width="960" height="720" />

Congratulations to Fujian Haixi Pharmaceutical Co., Ltd. (2637.HK) on its Successful Listing

Beijing Yunji Technology Co., Ltd. (the “Yunji”) is a leading hospitality robotic-based AI-empowered technology company. Yunji primarily offers robots and functional kits, complemented by services under AI digitalization system. From robots that interact with the physical world to AI digitalization system that streamline decision-making, Yunji delivers adaptive and scalable products and services to its customers.
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services in relation to share-based compensation and total equity value.
Congratulations again Beijing Yunji Technology Co., Ltd. (2670.HK) on its successful listing. The issue price of the shares is HKD 95.6 per share, and the amount of funds raised is HKD 659.6 million.

Congratulations to Beijing Yunji Technology Co., Ltd.(2670.HK) on its successful Listing on the Mainboard of HKSE on 16 Oct 2025

Congratulations to Shanghai Zhida Technology Development Co., Ltd. (2650.HK) on its successful Listing on the Mainboard of HKSE on 10 Oct 2025
Shanghai Zhida Technology Development Co., Ltd. was founded in 2010. It is a global leading enterprise in new energy vehicle charging and green energy digital technology, dedicated to taking "charging" as an entry point to promote new energy vehicles and green energy into families around the world, and contributing to the sustainable development of mankind. Its product portfolio includes smart home electric vehicle chargers and accessories, electric vehicle charging robots, EMS solutions, and pipeline products.
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services in relation to financial instruments, financial assets and impairment of long-term assets.
Congratulations again Shanghai Zhida Technology Development Co., Ltd. (2650.HK) on its successful listing. The issue price of the shares is  HKD66.92per share, and the amount of funds raised is HKD400.12 million.<img src="../../../../../uploads/EN_20003e37c2.JPG" alt="" width="960" height="720" />

Congratulations to Shanghai Zhida Technology Development Co., Ltd. (2650.HK) on its Successful Listing

AVISTA Group is proud to serve as an employer partner of Seeding Culture’s GCE Internship Scheme, an initiative dedicated to supporting youth development in music, arts, sports, and holistic growth. The program also promotes cross-cultural understanding and global perspectives among young talents. The Hong Kong sharing session was officiated by Mr. Woo Kin Man, MH, JP, Under Secretary for Constitutional and Mainland Affairs. Our Managing Partner, Mr. Vincent Pang, along with representatives from Hong Kong’s eight public universities and other partner employers, was invited to attend this meaningful event. The session provided a valuable platform for interns to reconnect and reflect on their internship experiences in Mainland China.
At AVISTA Group, we are committed to our corporate social responsibility and the cultivation of young talent. Through participation in various exchange programs, we offer opportunities for youth to gain workplace exposure and broaden their professional horizons, helping them grow into future leaders with international perspectives and professional skills.
Looking ahead, AVISTA Group will continue to support youth development initiatives and contribute to fostering greater collaboration and exchange between young people in Hong Kong and Mainland China, nurturing more outstanding talent for the future.
<img src="../../../../../uploads/APE_2423_cebd1904e6.jpg" alt="" width="800" height="309" />
<img src="../../../../../uploads/APZ_0233_cfd356fe20.jpg" alt="" width="800" />
<img src="../../../../../uploads/APE_2170_4a064208c7.jpg" alt="" width="800" />

News